Carla Angelozzi

992 total citations
8 papers, 569 citations indexed

About

Carla Angelozzi is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Carla Angelozzi has authored 8 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Surgery. Recurrent topics in Carla Angelozzi's work include RNA modifications and cancer (6 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Congenital Anomalies and Fetal Surgery (2 papers). Carla Angelozzi is often cited by papers focused on RNA modifications and cancer (6 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Congenital Anomalies and Fetal Surgery (2 papers). Carla Angelozzi collaborates with scholars based in Italy, United Kingdom and United States. Carla Angelozzi's co-authors include Christina Brahe, Francesco Danilo Tiziano, Giovanni Neri, Enrico Bertini, Tiziana Vitali, Eugenio Mercuri, Catia Andreassi, Marcello Villanova, Anna Maria Pinto and Alma Boninsegna and has published in prestigious journals such as Journal of Medical Genetics, European Journal of Human Genetics and Neuromuscular Disorders.

In The Last Decade

Carla Angelozzi

8 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carla Angelozzi Italy	6	453	442	168	79	27	8	569
Tiziana Vitali Italy	7	462 1.0×	407 0.9×	149 0.9×	81 1.0×	22 0.8×	12	560
Christine J. DiDonato United States	10	383 0.8×	376 0.9×	135 0.8×	28 0.4×	11 0.4×	13	466
Jennifer A. Markowitz United States	8	294 0.6×	336 0.8×	121 0.7×	36 0.5×	37 1.4×	8	449
Markus McColly United States	5	269 0.6×	250 0.6×	165 1.0×	87 1.1×	20 0.7×	12	408
Camille Rochette Canada	10	762 1.7×	779 1.8×	306 1.8×	53 0.7×	16 0.6×	10	856
P Burlet France	12	654 1.4×	660 1.5×	264 1.6×	135 1.7×	16 0.6×	21	816
Muna El-Khairi Switzerland	8	334 0.7×	469 1.1×	251 1.5×	36 0.5×	14 0.5×	20	526
Sayaka Hashimoto United States	8	236 0.5×	187 0.4×	94 0.6×	96 1.2×	10 0.4×	20	391
Mert Karakaya Germany	11	245 0.5×	186 0.4×	95 0.6×	40 0.5×	48 1.8×	22	358
Natalie F. Reash United States	7	214 0.5×	153 0.3×	97 0.6×	83 1.1×	17 0.6×	20	314

Countries citing papers authored by Carla Angelozzi

Since Specialization

Citations

This map shows the geographic impact of Carla Angelozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Angelozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Angelozzi more than expected).

Fields of papers citing papers by Carla Angelozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Angelozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Angelozzi. The network helps show where Carla Angelozzi may publish in the future.

Co-authorship network of co-authors of Carla Angelozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Angelozzi. A scholar is included among the top collaborators of Carla Angelozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Angelozzi. Carla Angelozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Fuso, Leonello, et al.. (2013). Polymorphism of Beta2-Adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary Results. INFM-OAR (INFN Catania). 2013. 1–6. 5 indexed citations

Tiziano, Francesco Danilo, Anna Maria Pinto, Sonia Messina, et al.. (2010). Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. Journal of Medical Genetics. 47(12). 856–858. 58 indexed citations

Angelozzi, Carla, et al.. (2007). Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. Journal of Medical Genetics. 45(1). 29–31. 67 indexed citations

Bussu, Francesco, Francesco Danilo Tiziano, Anna Maria Pinto, et al.. (2007). Arg16gly Polymorphism of the beta2-Adrenoceptor Gene (ADRBeta2) as a Susceptibility Factor for Nasal Polyposis. American Journal of Rhinology. 21(3). 378–382. 8 indexed citations

Brahe, Christina, Tiziana Vitali, Francesco Danilo Tiziano, et al.. (2004). Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. European Journal of Human Genetics. 13(2). 256–259. 129 indexed citations

Andreassi, Catia, Carla Angelozzi, Francesco Danilo Tiziano, et al.. (2003). Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. European Journal of Human Genetics. 12(1). 59–65. 203 indexed citations

Mercuri, Eugenio, Enrico Bertini, Sonia Messina, et al.. (2003). Pilot trial of phenylbutyrate in spinal muscular atrophy. Neuromuscular Disorders. 14(2). 130–135. 97 indexed citations

Andreassi, Catia, Carla Angelozzi, Tiziana Vitali, et al.. (2002). Upregulation of SMN2 gene expression by 4-phenylbutyrate: relevance for a therapeutic approach to spinal muscular atrophy.. UCL Discovery (University College London). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact